A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy
Authors:
- Diane LeComteDLDiane LeComte
- Louise TraylorLTLouise Traylor
- Richard C. HubbardRHRichard C. Hubbard
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 191 (4) , 1183-1191
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effective Treatment of Laparoscopic Cholecystectomy Pain with Intravenous Followed by Oral COX-2 Specific InhibitorAnesthesia & Analgesia, 2004
- A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal SubjectsThe Journal of Clinical Pharmacology, 2001
- Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator—controlled clinical trialClinical Therapeutics, 2001
- A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post—oral surgery pain modelClinical Therapeutics, 2001
- Parecoxib (Parecoxib Sodium)Drugs, 2001
- Postoperative opioid analgesia: Time for a reconsideration?Journal of Clinical Anesthesia, 1996
- Parenteral Ketorolac and Risk of Gastrointestinal and Operative Site BleedingJAMA, 1996
- Practice Guidelines for Acute Pain Management in the Perioperative SettingAnesthesiology, 1995
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971